Q2 EPS Forecast for Corcept Therapeutics Raised by Analyst
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Analysts at Zacks Research boosted their Q2 2025 EPS estimates for Corcept Therapeutics in a report released on Wednesday, March 19th. Zacks Research analyst K. Das now forecasts that the biotechnology company will post earnings of $0.37 per share for the quarter, up from their previous estimate […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Analysts at Zacks Research boosted their Q2 2025 EPS estimates for Corcept Therapeutics in a report released on Wednesday, March 19th. Zacks Research analyst K. Das now forecasts that the biotechnology company will post earnings of $0.37 per share for the quarter, up from their previous estimate […]
